Literature DB >> 23937391

The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds.

Robert Udelsman1, Yawei Zhang.   

Abstract

BACKGROUND: The incidence of thyroid cancer has increased at an alarming rate in both men and women in the United States. The etiology of this epidemic is unclear. We tested the hypothesis that a significant component of this epidemic is due to increased detection of occult disease. We examined whether the density of endocrinologists and general surgeons as well as employment of cervical ultrasonography were factors associated with this epidemic.
METHODS: Thyroid cancer incidence rates by states were obtained from the United States Cancer Statistics 1999-2009 reported by the National Program of Cancer Registries. The densities of endocrinologists and general surgeons and the employment of cervical ultrasonography were calculated on a statewide basis and correlated with the incidence of thyroid cancer.
RESULTS: Age-standardized incidence rates of thyroid cancer have increased in every state in the United States. Significant regional variations were noted, with the highest incidence rates in the northeast and the lowest in the south. The incidence rates were significantly correlated with the density of endocrinologists (r = 0.58, p<0.0001 for males; r = 0.44, p = 0.0031 for females) and the employment of cervical ultrasonography (r = 0.40, p = 0.0091 for males; r = 0.36, p = 0.0197 for females). Both the density of endocrinologists and general surgeons and employment of cervical ultrasonography could explain 57% of the variability in state-level incidence for males and 49% for females.
CONCLUSIONS: These data offer evidence to suggest that the epidemic of thyroid cancer is due to increased detection of a reservoir of previously occult disease. The increased detection of thyroid cancer results in therapeutic interventions including surgery and radioactive thyroid treatment that may be of limited benefit.

Entities:  

Mesh:

Year:  2013        PMID: 23937391      PMCID: PMC3949447          DOI: 10.1089/thy.2013.0257

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  28 in total

Review 1.  Overdiagnosis in cancer.

Authors:  H Gilbert Welch; William C Black
Journal:  J Natl Cancer Inst       Date:  2010-04-22       Impact factor: 13.506

2.  Trends in the utilization of medical procedures that use ionizing radiation.

Authors:  Mythreyi Bhargavan
Journal:  Health Phys       Date:  2008-11       Impact factor: 1.316

3.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

4.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

5.  Polybrominated diphenyl ether flame retardants in the U.S. population: current levels, temporal trends, and comparison with dioxins, dibenzofurans, and polychlorinated biphenyls.

Authors:  Arnold Schecter; Olaf Päpke; Kuang Chi Tung; Jean Joseph; T Robert Harris; James Dahlgren
Journal:  J Occup Environ Med       Date:  2005-03       Impact factor: 2.162

6.  An observational trial for papillary thyroid microcarcinoma in Japanese patients.

Authors:  Yasuhiro Ito; Akira Miyauchi; Hiroyuki Inoue; Mitsuhiro Fukushima; Minoru Kihara; Takuya Higashiyama; Chisato Tomoda; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

7.  A birth cohort analysis of the incidence of papillary thyroid cancer in the United States, 1973-2004.

Authors:  Cairong Zhu; Tongzhang Zheng; Briseis A Kilfoy; Xuesong Han; Shuangge Ma; Yue Ba; Yana Bai; Rong Wang; Yong Zhu; Yawei Zhang
Journal:  Thyroid       Date:  2009-10       Impact factor: 6.568

8.  Iodine status of the U.S. population, National Health and Nutrition Examination Survey, 2005–2006 and 2007–2008.

Authors:  Kathleen L Caldwell; Amir Makhmudov; Elizabeth Ely; Robert L Jones; Richard Y Wang
Journal:  Thyroid       Date:  2011-04       Impact factor: 6.568

9.  Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study.

Authors:  Cari L Meinhold; Elaine Ron; Sara J Schonfeld; Bruce H Alexander; D Michal Freedman; Martha S Linet; Amy Berrington de González
Journal:  Am J Epidemiol       Date:  2009-11-30       Impact factor: 4.897

10.  Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and chlorinated paraffins (CPs) in rats-testing interactions and mechanisms for thyroid hormone effects.

Authors:  Sara Hallgren; Per Ola Darnerud
Journal:  Toxicology       Date:  2002-08-15       Impact factor: 4.221

View more
  70 in total

Review 1.  Thyroid cancer in 2013: Advances in our understanding of differentiated thyroid cancer.

Authors:  Christoph Reiners
Journal:  Nat Rev Endocrinol       Date:  2013-12-03       Impact factor: 43.330

Review 2.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

3.  Diagnostic radiography exposure increases the risk for thyroid microcarcinoma: a population-based case-control study.

Authors:  Yawei Zhang; Yingtai Chen; Huang Huang; Jason Sandler; Min Dai; Shuangge Ma; Robert Udelsman
Journal:  Eur J Cancer Prev       Date:  2015-09       Impact factor: 2.497

Review 4.  Differentiated thyroid cancer-personalized therapies to prevent overtreatment.

Authors:  Markus Luster; Theresia Weber; Frederik A Verburg
Journal:  Nat Rev Endocrinol       Date:  2014-07-01       Impact factor: 43.330

Review 5.  Clinical Endocrinology in the near future: a post-modern challenge.

Authors:  F Trimarchi
Journal:  J Endocrinol Invest       Date:  2014-10-01       Impact factor: 4.256

6.  Nasal symptoms after radioiodine therapy: a rarely described side effect with similar frequency to lacrimal dysfunction.

Authors:  Jacqueline Jonklaas
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

7.  Response to the commentary letter entitled 'Diagnostic radiography and thyroid cancer - causation or simply an association?' to our article entitled 'Diagnostic radiography exposure increases the risk for thyroid microcarcinoma: a population-based case-control study' that was published in the European Journal of Cancer Prevention 2015; 24(5):439-446.

Authors:  Yawei Zhang; Huang Huang; Jason Sandler; Robert Udelsman
Journal:  Eur J Cancer Prev       Date:  2016-11       Impact factor: 2.497

8.  Use of Dietary Vitamin Supplements and Risk of Thyroid Cancer: A Population-Based Case-Control Study in Connecticut.

Authors:  Christopher Kim; Huang Huang; Nan Zhao; Catherine C Lerro; Min Dai; Yingtai Chen; Ni Li; Shuangge Ma; Robert Udelsman; Yawei Zhang
Journal:  Int J Vitam Nutr Res       Date:  2017-04-24       Impact factor: 1.784

Review 9.  Thyroid nodules and cancer management guidelines: comparisons and controversies.

Authors:  Fadi Nabhan; Matthew D Ringel
Journal:  Endocr Relat Cancer       Date:  2016-12-13       Impact factor: 5.678

10.  Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.

Authors:  R Michael Tuttle; James A Fagin; Gerald Minkowitz; Richard J Wong; Benjamin Roman; Snehal Patel; Brian Untch; Ian Ganly; Ashok R Shaha; Jatin P Shah; Mark Pace; Duan Li; Ariadne Bach; Oscar Lin; Adrian Whiting; Ronald Ghossein; Inigo Landa; Mona Sabra; Laura Boucai; Stephanie Fish; Luc G T Morris
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-10-01       Impact factor: 6.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.